Integral Health Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-150,000
Closed -$3.09M 89
2024
Q1
$3.09M Buy
+150,000
New +$3.22M 0.29% 76
2023
Q4
Sell
-325,000
Closed -$9.63M 78
2023
Q3
$9.63M Sell
325,000
-87,000
-21% -$3.06M 1.33% 28
2023
Q2
$14.7M Buy
412,000
+62,000
+18% +$1.78M 1.83% 14
2023
Q1
$8.2M Sell
350,000
-125,000
-26% -$3.57M 1.65% 26
2022
Q4
$12.9M Buy
475,000
+25,000
+6% +$1.14M 2.71% 14
2022
Q3
$24.2M Buy
450,000
+64,709
+17% +$3.32M 4.71% 1
2022
Q2
$15.5M Buy
385,291
+285,291
+285% +$14.1M 3.2% 6
2022
Q1
$6.62M Buy
+100,000
New +$6.84M 1.72% 21
2021
Q1
Sell
-35,000
Closed -$4.51M 79
2020
Q4
$4.51M Buy
35,000
+5,000
+17% +$575K 1.34% 28
2020
Q3
$3.35M Buy
+30,000
New +$2.74M 1.03% 35
2020
Q1
Sell
-70,000
Closed -$5.47M 63
2019
Q4
$5.47M Buy
+70,000
New +$5.04M 2.13% 21

Other funds holding GH

Integral Health Asset Management's GH Position: Q2 2024 in Review

Integral Health Asset Management sold out of Guardant Health (GH) in Q2 2024, closing a stake of 150,000 shares — an estimated $3.09M sold.

Integral Health Asset Management first reported a position in GH in Q4 2019 and held it in 11 quarters. The position peaked at $24.2M in Q3 2022. 281 funds tracked by Wall St. Rank hold GH as of Q2 2024.

  • Integral Health Asset Management reported no remaining Guardant Health position as of Q2 2024 after selling out during the quarter.
  • Integral Health Asset Management sold 150,000 Guardant Health shares in Q2 2024, an estimated $3.09M.
  • Integral Health Asset Management first reported a position in Guardant Health in Q4 2019 and held it in 11 quarters.
  • Integral Health Asset Management's Guardant Health position peaked at $24.2M in Q3 2022.
  • 281 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Integral Health Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.